Chinese english Germany Japanese Korea

N-(3-Hydroxypicolinoyl)-cyclo[L-Thr*-D-Abu-L-Pro-4-(dimethylamino)-N-methyl-L-Phe-4-oxo-5-hydroxy-L-Hpr-L-phenyl Gly-]

N-(3-Hydroxypicolinoyl)-cyclo[L-Thr*-D-Abu-L-Pro-4-(dimethylamino)-N-methyl-L-Phe-4-oxo-5-hydroxy-L-Hpr-L-phenyl Gly-] Struktur
31508-69-7
CAS-Nr.
31508-69-7
Englisch Name:
N-(3-Hydroxypicolinoyl)-cyclo[L-Thr*-D-Abu-L-Pro-4-(dimethylamino)-N-methyl-L-Phe-4-oxo-5-hydroxy-L-Hpr-L-phenyl Gly-]
Synonyma:
E-129Z3;Ostreogrycin B3;Ostreogrycin B3 (8CI,9CI);N-(3-Hydroxypicolinoyl)-cyclo[L-Thr*-D-Abu-L-Pro-4-(dimethylamino)-N-methyl-L-Phe-4-oxo-5-hydroxy-L-Hpr-L-phenyl Gly-]
CBNumber:
CB72296965
Summenformel:
C45H54N8O11
Molgewicht:
882.96
MOL-Datei:
31508-69-7.mol
Request For Quotation

N-(3-Hydroxypicolinoyl)-cyclo[L-Thr*-D-Abu-L-Pro-4-(dimethylamino)-N-methyl-L-Phe-4-oxo-5-hydroxy-L-Hpr-L-phenyl Gly-] Eigenschaften

Sicherheit

N-(3-Hydroxypicolinoyl)-cyclo[L-Thr*-D-Abu-L-Pro-4-(dimethylamino)-N-methyl-L-Phe-4-oxo-5-hydroxy-L-Hpr-L-phenyl Gly-] Chemische Eigenschaften,Einsatz,Produktion Methoden

N-(3-Hydroxypicolinoyl)-cyclo[L-Thr*-D-Abu-L-Pro-4-(dimethylamino)-N-methyl-L-Phe-4-oxo-5-hydroxy-L-Hpr-L-phenyl Gly-] Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

N-(3-Hydroxypicolinoyl)-cyclo[L-Thr*-D-Abu-L-Pro-4-(dimethylamino)-N-methyl-L-Phe-4-oxo-5-hydroxy-L-Hpr-L-phenyl Gly-] Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
BOC Sciences 		+16314854226
 inquiry@bocsci.com United States 19743 58
Zhejiang Huida Biotech Co., LTD 0571-89903882 13626641628
 jiangnan@huidabiotech.com China 3661 58
Zhejiang Huida Biotech Co., LTD 0571-0571-89903882 15990081639
 sunshixuan@huidabiotech.com China 3705 58
  • E-129Z3
  • N-(3-Hydroxypicolinoyl)-cyclo[L-Thr*-D-Abu-L-Pro-4-(dimethylamino)-N-methyl-L-Phe-4-oxo-5-hydroxy-L-Hpr-L-phenyl Gly-]
  • Ostreogrycin B3
  • Ostreogrycin B3 (8CI,9CI)
  • 31508-69-7
  • C45H54N8O11
Copyright 2019 © ChemicalBook. All rights reserved